Cargando…

Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease

Long-term intake of potential zinc-chelating drugs may cause zinc deficiency. We postulated that zinc deficiency in Parkinson’s disease (PD) patients was related to the intake of drugs such as levodopa. We investigated the relationship between zinc levels and levodopa administration period, dosage,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuyama, Hirofumi, Matsuura, Keita, Ishikawa, Hidehiro, Hirata, Yoshinori, Kato, Natsuko, Niwa, Atsushi, Narita, Yugo, Tomimoto, Hidekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621473/ https://www.ncbi.nlm.nih.gov/pubmed/34836369 http://dx.doi.org/10.3390/nu13114114

Ejemplares similares

Proposition of zinc supplementation during levodopa–carbidopa intestinal gel treatment
por: Matsuyama, Hirofumi, et al.
Publicado: (2018)

MEFV gene mutations in neuro‐Behçet's disease and neuro‐Sweet disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2019)

Association between behavioral and psychological symptoms and cerebral small vessel disease MRI findings in memory clinic patients
por: Shinohara, Masaki, et al.
Publicado: (2023)

Relationship of brain edema after deep brain stimulation surgery with motor and cognitive function
por: Nishiguchi, Yamato, et al.
Publicado: (2022)

Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report
por: Sakano, Shoko, et al.
Publicado: (2020)

Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis
por: Tachibana, Kei, et al.
Publicado: (2020)

Clinical Features and Experimental Models of Cerebral Small Vessel Disease
por: Shindo, Akihiro, et al.
Publicado: (2020)

Cerebral Embolism Associated with Calcified Amorphous Tumor: A Review of Cerebral Infarction Cases
por: Nishiguchi, Yamato, et al.
Publicado: (2021)

Micro-MRI improves the accuracy of clinical diagnosis in cerebral small vessel disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2021)

Magnetic resonance imaging and neuropsychological findings for predicting of cognitive deterioration in memory clinic patients
por: Matsuda, Kana, et al.
Publicado: (2023)

An Investigation of Perspectives of Respite Admission Among People Living With Amyotrophic Lateral Sclerosis and the Hospitals That Support Them
por: Nakai, Michiko, et al.
Publicado: (2017)

Investigation of hypertensive arteriopathy-related and cerebral amyloid angiopathy-related small vessel disease scores in patients from a memory clinic: a prospective single-centre study
por: Matsuda, Kana, et al.
Publicado: (2021)

Pulvinar quantitative susceptibility mapping predicts visual hallucinations post‐deep brain stimulation in Parkinson's disease
por: Matsuura, Keita, et al.
Publicado: (2023)

Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient
por: Miyashita, Koichi, et al.
Publicado: (2023)

Vertebral artery dissection associated with familial Mediterranean fever and Behçet's disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2019)

Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson’s disease
por: Kim, Joung Eun, et al.
Publicado: (2023)

Deep Brain Stimulation in a Patient with Parkinson's Disease and Cortical Superficial Siderosis
por: Shiraishi, Makoto, et al.
Publicado: (2022)

Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study
por: Matsushita, Futoshi, et al.
Publicado: (2018)

Impairment of intermediate somatosensory function in corticobasal syndrome
por: Matsuda, Kana, et al.
Publicado: (2020)

Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
por: Nishiguchi, Yamato, et al.
Publicado: (2021)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology
por: Niwa, Atsushi, et al.
Publicado: (2017)

Low Pulvinar Intensity in Susceptibility-Weighted Imaging May Suggest Cognitive Worsening After Deep Brain Stimulation Therapy in Patients With Parkinson's Disease
por: Matsuura, Keita, et al.
Publicado: (2019)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
por: Soares, Nayron Medeiros, et al.
Publicado: (2023)

Brain magnetic resonance imaging and cognitive alterations after ablation in patients with atrial fibrillation
por: Kato, Natsuko, et al.
Publicado: (2021)

Continuous levodopa for advanced Parkinson’s disease
por: Lundqvist, Christofer
Publicado: (2007)

Levodopa-Responsive Benign Tremulous Parkinsonism
por: Kano, Osamu, et al.
Publicado: (2013)

Mortality in Levodopa-Treated Parkinson's Disease
por: Morgan, John C., et al.
Publicado: (2014)

Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy
por: Hirata, Yoshinori, et al.
Publicado: (2022)

Modulation of Habit Formation by Levodopa in Parkinson's Disease
por: Marzinzik, Frank, et al.
Publicado: (2011)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Successful Utilization of Levodopa in HIV-Induced Parkinsonism
por: Almajali, Mohammad, et al.
Publicado: (2020)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
por: Goyal, Sheetal, et al.
Publicado: (2022)

Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor
por: Lee, Phil Hyu, et al.
Publicado: (2011)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome
por: Palat, Padmini, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t3uuuou1indgi04g1plelaro0u